Erol R. Akdamar - 13 Nov 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
Group President
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
13 Nov 2023
Net transactions value
-$1,921,795
Form type
4
Filing time
15 Nov 2023, 17:37:58 UTC
Previous filing
02 May 2023
Next filing
02 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $1,286,795 +26,825 $47.97* 26,825 13 Nov 2023 Direct
transaction HCA Common Stock Tax liability $3,208,590 -13,951 -52% $229.99 12,874 13 Nov 2023 Direct
holding HCA Common Stock 42,484 13 Nov 2023 By Family Trust
holding HCA Common Stock 60,000 13 Nov 2023 By LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -14,500 -100% $0.000000* 0 13 Nov 2023 Common Stock 14,500 $47.97 Direct F1
transaction HCA Stock Appreciation Right Options Exercise $0 -12,325 -100% $0.000000* 0 13 Nov 2023 Common Stock 12,325 $47.97 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
F2 The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.